It is our first commercial product licensing deal, and we look forward to a long-term mutually beneficial relationship with RST Sanexas. We anticipate follow-on orders as well as additional licensing agreements from others for our potent and proprietary technology in the form of plant-based ingredients used in products throughout the health care and pain management product spectrum."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.